# Osteoporosis Treatment in Post-menopausal Women

> **NCT03006003** · PHASE4 · UNKNOWN · sponsor: **Taichung Veterans General Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Depressive Syndrome

## Interventions

- **DRUG:** Raloxifene
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT03006003
- **Lead sponsor:** Taichung Veterans General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006003, "Osteoporosis Treatment in Post-menopausal Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03006003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*